Apexigen
phase durable confirmed responses to combination | Apexigen
Company
Deck Type
Sector
Industry
Deck date
September 2022
Slide
15 of 27
Related slides by other companies
Alkermes
Investor Day
March 2021
artistry in combination with case study year old ovarian cancer patient artistry part efficacy diagnosis on study tumor shrinkage high grade serous ovarian cancer status unknown status wild type platinum resistant prior treatment change in target lesions from cycle stable disease reduction cycle stable disease reduction cycle stable disease reduction line therapy duration mos best response cycle partial response reduction last dose not evaluable patient has remained on treatment for months treatment related aes manageable with no dose modifications majority aes grade and grade elevated alt and grade anemia notes continues on therapy as of march per criteria reported after the data cut off and awaiting confirmation progressive disease partial response stable disease data cut off march | Alkermes
Genelux
Investor Presentation
December 2023
systemic administration generated encouraging data expanded access program | Genelux
Nuvalent
Investor Presentation
February 2024
activity induced intracranial responses in patients with refractory alk phase refractory complete response alk fusion alk fusion no known resistance mutations lines of therapy including and chemotherapy complete resolution of parietal parenchymal brain metastases after weeks treatment continues at months ongoing mutation weeks resistance alk fusion partial response ongoing confirmed lines of therapy consisting treatment continues at after weeks of and months weeks confirmed courtesy of and hospital vall barcelona courtesy of university united states data as of august central nervous system complete response non small source lin cell lung cancer partial response once daily tyrosine kinase inhibitor | Nuvalent
AN2 Therapeutics
Investor Presentation
February 2025
clear and improving clinical response as measured by | AN2 Therapeutics
Other recent decks by Apexigen
See all presentations (2 decks)
SPAC
March 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights